|
Sign In to gain access to subscriptions and/or personal tools.
|
Transforming Growth Factor-β and Interleukin 10 in Oral Implant Sites in Humans
G. Schierano1,
G. Bellone2,
E. Cassarino1,
M. Pagano3,
G. Preti1,* and
G. Emanuelli2
1 Department of Prosthetic Dentistry,
2 Department of Clinical Physiopathology, and
3 Department of Biomedical Sciences and Human Oncology, University of Turin, Corso Dogliotti 14, 10126 Torino, Italy;
Correspondence: *corresponding author, giulio.preti{at}unito.it
Cross-talk between cells and cytokines in peri-implant tissue is largely unknown. The immune response in the gingival mucosa appears to favor implant integration over rejection, since titanium-implant-retained overdentures show long-term success. This study evaluates pro-inflammatory (interleukin [IL]-2, interferon [IFN]- , IL-12) and anti-inflammatory (IL-4, IL-10, transforming growth factor [TGF]-β1) cytokine mRNA expression and tissue morphometry in peri-implant soft tissue from patients before and during treatment with Brånemark titanium implants. Immediately after treatment with endosseous implant and overdenture, TGF-β1 mRNA increased in peri-implant mucosa specimens; transcript accumulation for IL-10 was elevated at 4 months and decreased dramatically thereafter. Transcripts for IL-2, IFN- , IL-12, and IL-4 were absent. Healthy osseointegrated implants showed no histological inflammation in most patients. These findings suggest that newly classified TGF-β and/or IL-10 secreting T regulatory (r)/T helper (h)-3 cells may populate implant insertion sites.
Key Words: Th1 Th2 Th3 cytokines oral implants
Journal of Dental Research, Vol. 82, No. 6,
428-432 (2003)
DOI: 10.1177/154405910308200605

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|